TR
Healthcare & Life Sciences
Trioar
South Koreatrioar.co.kr/
Trioar is a Healthcare & Life Sciences startup based in South Korea, most recent round Series B.
Activeseries-b
series-b
Stage
About Trioar
Trioar is a company headquartered in South Korea. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences.
Trioar develops next-generation antibody-drug conjugate (ADC) platforms to improve the efficacy and safety of antibody-based cancer therapeutics through proprietary linker-toxin technologies and tumor-targeting strategies.
Explore Trioar's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.